Thus, the downregulation of Glut-1 and the upregulation of the fatty acid transporter SLC27A1 in DLBCL indicate a shift from a glycolytic to an oxidative metabolism during lymphoma progression (Fig. 4). The gene discussed is SLC2A1; the disease is lymphoma.